2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2005
November 17, 2005
Aegera’s AEG35156 phase 1 oncology trial demonstrates target response in cancer patients
November 07, 2005
Aegera presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutic
September 21, 2005
Aegera initiates phase 1 combination oncology trial of XIAP antisense
September 19, 2005
New publications on XIAP and islet cell transplantation – XIAP a key player in the treatment of type 1 diabetes
July 06, 2005
Aegera Therapeutics appoints Dr. Jacques Jolivet as Vice President, Clinical
May 16, 2005
FOCIS 2005 presentation: XIAP a novel target in multiple sclerosis
January 10, 2005
Aegera welcomes two new independent board members with significant biotechnology expertise
About Aegera
|
Pipeline
|
Clinical Trials
|
Partnerships
|
Media
|
Careers
|
Contact Us
|
Français
© 2010 Aegera Therapeutics Inc. All rights reserved. Developed by
Grafika Designs
.
